ProCE Banner Activity

Anti-CD20 Antibodies in CLL: What to Do in Regular Practice

Clinical Thought
How I select between available anti-CD20 antibodies for patients with CLL.

Released: July 09, 2015

Expiration: July 07, 2016

No longer available for credit.

Share

Faculty

John M. Burke

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Gilead

Faculty Disclosure

Primary Author

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

John M. Burke, MD, has disclosed that he has received consulting fees from Janssen and funds for research support from TG Therapeutics.